BIOFILCHEMPharmaceuticals
Biofil Chemicals & Pharmaceuticals Ltd — Balance Sheet
₹25.79
-4.48%
Biofil Chemicals & Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 1.63 Cr | 1.63 Cr | 1.63 Cr | 1.63 Cr | — |
| Share Issued | 1.63 Cr | 1.63 Cr | 1.63 Cr | 1.63 Cr | — |
| Net Debt | 0.34 Cr | 0.35 Cr | 0.48 Cr | 0.32 Cr | — |
| Total Debt | 0.47 Cr | 0.44 Cr | 0.52 Cr | 0.46 Cr | — |
| Tangible Book Value | 18.78 Cr | 18.20 Cr | 17.30 Cr | 16.84 Cr | — |
| Invested Capital | 19.25 Cr | 18.64 Cr | 17.82 Cr | 17.30 Cr | — |
| Working Capital | 10.71 Cr | 9.88 Cr | 8.63 Cr | 7.82 Cr | — |
| Net Tangible Assets | 18.78 Cr | 18.20 Cr | 17.30 Cr | 16.84 Cr | — |
| Common Stock Equity | 18.78 Cr | 18.20 Cr | 17.30 Cr | 16.84 Cr | — |
| Total Capitalization | 18.78 Cr | 18.20 Cr | 17.30 Cr | 16.84 Cr | — |
| Total Equity Gross Minority Interest | 18.78 Cr | 18.20 Cr | 17.30 Cr | 16.84 Cr | — |
| Stockholders Equity | 18.78 Cr | 18.20 Cr | 17.30 Cr | 16.84 Cr | — |
| Other Equity Interest | 2.51 Cr | 1.93 Cr | 1.03 Cr | 0.56 Cr | — |
| Capital Stock | 16.27 Cr | 16.27 Cr | 16.27 Cr | 16.27 Cr | — |
| Common Stock | 16.27 Cr | 16.27 Cr | 16.27 Cr | 16.27 Cr | — |
| Total Liabilities Net Minority Interest | 32.18 Cr | 28.88 Cr | 14.10 Cr | 1.89 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 0.33 Cr | 0.36 Cr | 0.38 Cr | 0.40 Cr | — |
| Other Non Current Liabilities | -1000.00 | — | — | -1000.00 | — |
| Non Current Deferred Taxes Liabilities | 0.33 Cr | 0.36 Cr | 0.38 Cr | 0.40 Cr | — |
| Current Liabilities | 31.85 Cr | 28.52 Cr | 13.73 Cr | 1.49 Cr | — |
| Other Current Liabilities | 0.18 Cr | 1000.00 | -30000.00 | -1000.00 | — |
| Current Debt And Capital Lease Obligation | 0.47 Cr | 0.44 Cr | 0.52 Cr | 0.46 Cr | — |
| Current Debt | 0.47 Cr | 0.44 Cr | 0.52 Cr | 0.46 Cr | — |
| Current Provisions | 0.21 Cr | 0.24 Cr | 0.23 Cr | 0.27 Cr | — |
| Payables | 30.99 Cr | 27.70 Cr | 12.97 Cr | 0.76 Cr | — |
| Accounts Payable | 30.99 Cr | 27.55 Cr | 12.65 Cr | 0.60 Cr | — |
| Total Assets | 50.96 Cr | 47.08 Cr | 31.41 Cr | 18.73 Cr | — |
| Total Non Current Assets | 8.41 Cr | 8.68 Cr | 9.05 Cr | 9.42 Cr | — |
| Other Non Current Assets | 0.06 Cr | -1000.00 | -1000.00 | -1000.00 | — |
| Net PPE | 8.34 Cr | 8.62 Cr | 9.00 Cr | 9.42 Cr | — |
| Current Assets | 42.55 Cr | 38.41 Cr | 22.35 Cr | 9.31 Cr | — |
| Other Current Assets | 0.64 Cr | 0.03 Cr | 0.24 Cr | 0.25 Cr | — |
| Inventory | 3.34 Cr | 2.55 Cr | 1.21 Cr | 1.29 Cr | — |
| Accounts Receivable | 38.31 Cr | 33.03 Cr | 20.50 Cr | 7.17 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 0.26 Cr | 2.28 Cr | 0.04 Cr | 0.14 Cr | — |
| Other Short Term Investments | 0.12 Cr | 2.19 Cr | 0.01 Cr | 0.06 Cr | — |
| Cash And Cash Equivalents | 0.13 Cr | 2.28 Cr | 0.04 Cr | 0.14 Cr | — |
| Fixed Assets Revaluation Reserve | — | 3.76 Cr | 3.76 Cr | 3.76 Cr | 3.76 Cr |
| Retained Earnings | — | -31.69 Cr | -32.60 Cr | -33.06 Cr | -33.77 Cr |
| Additional Paid In Capital | — | 8.33 Cr | 8.33 Cr | 8.33 Cr | 8.33 Cr |
| Current Deferred Taxes Liabilities | — | 0.24 Cr | 0.23 Cr | 0.27 Cr | 0.33 Cr |
| Other Payable | — | 0.15 Cr | 0.32 Cr | 0.16 Cr | 0.14 Cr |
| Non Current Prepaid Assets | — | 0.05 Cr | 0.05 Cr | — | — |
| Accumulated Depreciation | — | -3.03 Cr | -2.63 Cr | -2.20 Cr | -1.77 Cr |
| Gross PPE | — | 11.65 Cr | 11.63 Cr | 11.62 Cr | 11.55 Cr |
| Construction In Progress | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Properties | — | 0.24 Cr | 0.24 Cr | 0.24 Cr | 0.24 Cr |
| Machinery Furniture Equipment | — | 3.90 Cr | 3.90 Cr | 3.90 Cr | 3.83 Cr |
| Buildings And Improvements | — | 3.01 Cr | 2.99 Cr | 2.98 Cr | 2.98 Cr |
| Land And Improvements | — | 4.50 Cr | 4.50 Cr | 4.50 Cr | 4.50 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 0.52 Cr | 0.60 Cr | 0.25 Cr | 0.31 Cr |
| Other Inventories | — | -1000.00 | -1000.00 | — | — |
| Finished Goods | — | 0.80 Cr | 0.53 Cr | 0.23 Cr | 3.82 Cr |
| Work In Process | — | 0.00 | 0.00 | 0.10 Cr | 0.10 Cr |
| Raw Materials | — | 1.75 Cr | 0.68 Cr | 0.96 Cr | 0.43 Cr |
| Allowance For Doubtful Accounts Receivable | — | -0.13 Cr | -0.08 Cr | -0.03 Cr | 0.00 |
| Gross Accounts Receivable | — | 33.16 Cr | 20.59 Cr | 7.21 Cr | 17.22 Cr |
| Cash Equivalents | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Financial | — | 2.28 Cr | 0.04 Cr | 0.14 Cr | 0.44 Cr |
| Taxes Receivable | — | — | 0.27 Cr | 0.21 Cr | 0.07 Cr |
| Other Receivables | — | — | — | — | 0.05 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Biofil Chemicals & Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.